Matthew R. Henn - Insider Trading & Ownership

Entity
Individual
Location
C/O Seres Therapeutics, Inc., 200 Sidney Street, Cambridge, MA
Summary
The estimated net worth of Matthew R. Henn is at least $59.5K dollars as of November 19, 2024. Matthew R. Henn is the Chief Scientific Officer and EVP of Seres Therapeutics, Inc. and owns shares of Seres Therapeutics, Inc. (MCRB) stock worth about $59.5K.
All Insider Reports
All Insider Reports

Ownership of Matthew R. Henn

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MCRB Seres Therapeutics, Inc. Chief Scientific Officer and EVP $59.5K -$9.37K -13.6% Nov 15, 2024

Insider Transactions Reported by Matthew R. Henn:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.